Compare CDW Corp. (CDW) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CDW Corp. vs State Street SPDR S&P Biotech ETF — how do they compare? CDW Corp. trades at $135.37 (market cap $16.92B), while State Street SPDR S&P Biotech ETF trades at $158.07. The key difference: CDW Corp. pays a 1.86% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, CDW Corp. nearer its low. Which is the better fit depends on your goals.
| CDW | XBI | |
|---|---|---|
Market Cap | $16.92B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $170.77 | $164.28 |
52-Week Low | $99.30 | $86.92 |
Enterprise Value | $22.52B | — |
Dividend Yield | 1.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
